Turkish thoracic society asthma management and prevention guideline: Key points; [Türk toraks derneǧi astım tanı ve tedavi rehberi: Anahtar noktalar]

Simple item page
dc.contributor.authorYildiz F.
dc.contributor.authorOǧuzülgen I.K.
dc.contributor.authorDursun B.
dc.contributor.authorMungan D.
dc.contributor.authorGemicioǧlu B.
dc.contributor.authorYorgancioǧlu A.
dc.date.accessioned2024-07-22T08:20:22Z
dc.date.available2024-07-22T08:20:22Z
dc.date.issued2011
dc.description.abstractAsthma still has high morbidity and cost despite all advances in pathogenesis, diagnosis and treatment. Although asthma can be controlled with proper diagnosis and treatment, the low rates of control in our country and in the world can not be attributed to the variable course of the disease and patients' psycho-social behaviours for chronic disease. In this context, Turkish Thoracic Society (TTS) has decided to update Asthma Diagnosis and Management Guide latest published in 2000. National data were collected, compiled and prepared by authors, and final form given by the TTS Asthma and Allergy Study Group, after presenting to consultant individuals and institutions. In June 2009, the National Asthma Management and Prevention Guideline were published in Turkish. In this paper, we aimed to present the national guide in English with its basics and individual differences.
dc.identifier.DOI-ID10.5578/tt.2750
dc.identifier.issn04941373
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/18120
dc.language.isoEnglish
dc.publisherAnkara University
dc.rightsAll Open Access; Green Open Access; Hybrid Gold Open Access
dc.subjectallergen
dc.subjectbeclometasone
dc.subjectbeta 2 adrenergic receptor stimulating agent
dc.subjectbudesonide
dc.subjectcholinergic receptor blocking agent
dc.subjectciclesonide
dc.subjectcorticosteroid
dc.subjectdecongestive agent
dc.subjectfluticasone
dc.subjectformoterol
dc.subjectimmunoglobulin E antibody
dc.subjectleukotriene receptor blocking agent
dc.subjectmometasone furoate
dc.subjectsalbutamol
dc.subjecttheophylline
dc.subjectarticle
dc.subjectartificial ventilation
dc.subjectaspirin exacerbated respiratory disease
dc.subjectasthma
dc.subjectclinical assessment tool
dc.subjectcoughing
dc.subjectdiet
dc.subjectdisease exacerbation
dc.subjectdrug monitoring
dc.subjectemergency care
dc.subjectenvironmental exposure
dc.subjectfollow up
dc.subjectforced expiratory volume
dc.subjectforced vital capacity
dc.subjectgastroesophageal reflux
dc.subjectgender
dc.subjecthealth care cost
dc.subjectheredity
dc.subjecthuman
dc.subjectindividuality
dc.subjectintensive care unit
dc.subjectlung function test
dc.subjectmedical society
dc.subjectmetered dose inhaler
dc.subjectnose polyp
dc.subjectobesity
dc.subjectoccupational asthma
dc.subjectoccupational hazard
dc.subjectoxygen therapy
dc.subjectpollution
dc.subjectpractice guideline
dc.subjectprevalence
dc.subjectrespiratory tract infection
dc.subjectrhinitis
dc.subjectrisk factor
dc.subjectrisk reduction
dc.subjectsinusitis
dc.subjectsmoking
dc.subjectsocioeconomics
dc.subjecttreatment response
dc.subjectTurkey (republic)
dc.titleTurkish thoracic society asthma management and prevention guideline: Key points; [Türk toraks derneǧi astım tanı ve tedavi rehberi: Anahtar noktalar]
dc.typeArticle

Files

Collections

Scopus Koleksiyonu